A detailed history of Conning Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Conning Inc. holds 214,087 shares of JNJ stock, worth $32.6 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
214,087
Previous 227,732 5.99%
Holding current value
$32.6 Million
Previous $33.3 Million 4.23%
% of portfolio
1.2%
Previous 1.25%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$145.48 - $167.38 $1.99 Million - $2.28 Million
-13,645 Reduced 5.99%
214,087 $34.7 Million
Q2 2024

Jul 26, 2024

BUY
$144.38 - $157.78 $803,041 - $877,572
5,562 Added 2.5%
227,732 $33.3 Million
Q1 2024

Apr 26, 2024

BUY
$155.22 - $162.74 $3.02 Million - $3.17 Million
19,449 Added 9.59%
222,170 $35.1 Million
Q4 2023

Jan 29, 2024

SELL
$145.6 - $158.88 $1.5 Million - $1.64 Million
-10,335 Reduced 4.85%
202,721 $31.8 Million
Q3 2023

Oct 26, 2023

SELL
$155.75 - $174.48 $994,775 - $1.11 Million
-6,387 Reduced 2.91%
213,056 $33.2 Million
Q2 2023

Jul 21, 2023

SELL
$154.35 - $166.11 $1.82 Million - $1.96 Million
-11,819 Reduced 5.11%
219,443 $36.3 Million
Q1 2023

Apr 27, 2023

BUY
$151.05 - $180.26 $3.94 Million - $4.7 Million
26,067 Added 12.7%
231,262 $35.8 Million
Q4 2022

Feb 07, 2023

SELL
$160.2 - $179.79 $464,900 - $521,750
-2,902 Reduced 1.39%
205,195 $36.2 Million
Q3 2022

Oct 28, 2022

SELL
$161.33 - $179.52 $4.37 Million - $4.86 Million
-27,094 Reduced 11.52%
208,097 $34 Million
Q2 2022

Jul 20, 2022

SELL
$168.19 - $186.01 $2.88 Million - $3.19 Million
-17,129 Reduced 6.79%
235,191 $41.7 Million
Q1 2022

May 02, 2022

SELL
$158.14 - $179.59 $5.37 Million - $6.1 Million
-33,979 Reduced 11.87%
252,320 $44.7 Million
Q4 2021

Jan 27, 2022

BUY
$155.93 - $173.01 $1.85 Million - $2.05 Million
11,865 Added 4.32%
286,299 $48.9 Million
Q3 2021

Nov 05, 2021

SELL
$161.5 - $179.47 $2.6 Million - $2.89 Million
-16,108 Reduced 5.54%
274,434 $44.3 Million
Q2 2021

Jul 29, 2021

SELL
$159.48 - $171.07 $449,255 - $481,904
-2,817 Reduced 0.96%
290,542 $47.8 Million
Q1 2021

Apr 23, 2021

SELL
$153.07 - $170.48 $1.04 Million - $1.16 Million
-6,784 Reduced 2.26%
293,359 $48.2 Million
Q4 2020

Jan 28, 2021

BUY
$137.11 - $157.38 $4.34 Million - $4.99 Million
31,679 Added 11.8%
300,143 $47.2 Million
Q3 2020

Oct 21, 2020

BUY
$140.38 - $153.83 $1.32 Million - $1.45 Million
9,400 Added 3.63%
268,464 $40 Million
Q2 2020

Aug 07, 2020

SELL
$128.81 - $155.51 $1.87 Million - $2.26 Million
-14,510 Reduced 5.3%
259,064 $36.4 Million
Q1 2020

Apr 29, 2020

SELL
$111.14 - $153.99 $1.57 Million - $2.17 Million
-14,090 Reduced 4.9%
273,574 $35.9 Million
Q4 2019

Jan 29, 2020

BUY
$127.5 - $146.44 $967,852 - $1.11 Million
7,591 Added 2.71%
287,664 $42 Million
Q3 2019

Oct 30, 2019

BUY
$126.95 - $142.14 $615,072 - $688,668
4,845 Added 1.76%
280,073 $36.2 Million
Q2 2019

Jul 25, 2019

SELL
$131.15 - $144.24 $4.14 Million - $4.55 Million
-31,572 Reduced 10.29%
275,228 $38.3 Million
Q1 2019

Apr 22, 2019

BUY
$125.72 - $139.79 $1.69 Million - $1.88 Million
13,439 Added 4.58%
306,800 $42.9 Million
Q4 2018

Jan 29, 2019

SELL
$122.84 - $147.84 $5.08 Million - $6.11 Million
-41,332 Reduced 12.35%
293,361 $37.9 Million
Q3 2018

Oct 26, 2018

SELL
$121.58 - $142.88 $2.73 Million - $3.21 Million
-22,488 Reduced 6.3%
334,693 $46.2 Million
Q2 2018

Jul 25, 2018

SELL
$119.4 - $131.76 $2.35 Million - $2.59 Million
-19,644 Reduced 5.21%
357,181 $43.3 Million
Q1 2018

May 04, 2018

BUY
$125.1 - $148.14 $5.38 Million - $6.37 Million
42,978 Added 12.87%
376,825 $48.3 Million
Q4 2017

Jan 30, 2018

SELL
$131.22 - $143.62 $3.26 Million - $3.56 Million
-24,817 Reduced 6.92%
333,847 $46.6 Million
Q3 2017

Oct 20, 2017

BUY
$129.47 - $135.38 $46.4 Million - $48.6 Million
358,664
358,664 $46.6 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $398B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Conning Inc. Portfolio

Follow Conning Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conning Inc. with notifications on news.